United States Brent Oil Fund LP vs Zimmer Biomet Holdings Inc — how do they compare? United States Brent Oil Fund LP trades at $49.78, while Zimmer Biomet Holdings Inc trades at $97.48 (market cap $18.67B). The key difference: Zimmer Biomet Holdings Inc pays a 0.98% dividend while United States Brent Oil Fund LP pays none. Which is the better fit depends on your goals.
| BNO | ZBH | |
|---|---|---|
Sector | Commodities - Energy | Health |
52-Week High | $60.13 | $107.71 |
52-Week Low | $27.20 | $79.58 |
Market Cap | — | $18.67B |
Enterprise Value | — | $25.74B |
Dividend Yield | — | 0.98% |
Signals from Pluang's Aura AI — not financial advice
BNO shows bullish momentum with a 1.22% gain to $50.72, supported by strong technical indicators including bullish moving averages. The oil market faces supply constraints from Middle East tensions and OPEC demand forecast cuts, creating volatility. Recent news highlights ongoing Strait of Hormuz disruptions affecting global oil flows, with the International Energy Agency warning of depleting stockpiles.
The outlook remains volatile with supply risks supporting prices, but demand destruction and inventory builds pose headwinds. Key resistance at $52 and support at $50 will determine near-term direction. Oil market fundamentals suggest continued price pressure from geopolitical factors, though weakening demand forecasts could limit upside potential.
Zimmer Biomet (ZBH) trades at $97.9, up 0.12% on the day, with a bullish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, supported by hips, specialty businesses, and technology. Key financials show a P/E of 23.6 and net income margin of 9.48%, while cash flow from operations improved to $1.70B in 2025.
The outlook is positive, with a consensus price target of $103.56 offering ~6% upside. Risks include competitive pressures and margin volatility, but consistent earnings beats and institutional accumulation support a constructive view for long-term investors.
Trailing returns across standard periods
BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.
Read more on BNO →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →